After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuticals and AstraZeneca found themselves in the final round of the annual #FierceMadness bracket competition. The trophy ultimately went to Apellis, but both companies’ commercials racked up plenty
read moreEven as tariffs start to impact its medtech business, Johnson & Johnson is lifting its sales guidance for 2025 thanks to a recent neuroscience buyout. More: As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations Source:
read moreSanofi has said “deal” to Chrissy Teigen. The model, cookbook author and “Deal or No Deal” banker has signed on as a celebrity spokesperson for Sanofi’s push to encourage people to screen early for Type 1 diabetes. More: Sanofi signs
read moreCamzyos came up short in a phase 3 trial weighing its use in patients with non-obstructive hypertrophic cardiomyopathy (nHCM). In 2022, the drug won FDA approval to treat certain patients with obstructive HCM. More: BMS growth driver Camzyos fails in
read moreA two-day meeting of the Advisory Committee on Immunization Practices, which was postponed by new HHS Secretary Robert F. Kennedy Jr., is underway today in Atlanta and will conclude with panel votes on several vaccines on Wednesday afternoon. More: After
read more
Long-term survival projections suggest improved outcomes for patients More: New data reinforce daratumumab as standard of care for multiple myeloma Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals